United States - English - NLM (National Library of Medicine)

rebel distributors corp - epinephrine (unii: ykh834o4bh) (epinephrine - unii:ykh834o4bh) - epinephrine 0.3 mg - epinephrine auto-injector is indicated in the emergency treatment of severe allergic reactions (type i) including anaphylaxis to stinging insects (e.g. order hymenoptera, which includes bees, wasps, hornets, yellow jackets and fire ants), and biting insects (e.g. triatoma, mosquitos), allergen immunotherapy, foods, drugs, diagnostic testing substances (e.g. radiocontrast media), and other allergens, as well as anaphylaxis to unknown substances (idiopathic anaphylaxis) or exercise-induced anaphylaxis. epinephrine auto-injector is intended for immediate administration in patients with a history of anaphylactic reactions. selection of the appropriate dosage strength is determined according to patient body weight (see dosage and administration section). such reactions may occur within minutes after exposure and consist of flushing, apprehension, syncope, tachycardia, thready or unobtainable pulse associated with a fall in blood pressure, convulsions, vomiting, diarrhea and abdominal cramps, involuntary voiding, w

United States - English - NLM (National Library of Medicine)

physicians total care, inc. - epinephrine (unii: ykh834o4bh) (epinephrine - unii:ykh834o4bh) - epinephrine 0.3 mg - epinephrine auto-injector is indicated in the emergency treatment of severe allergic reactions (type i) including anaphylaxis to stinging insects (e.g. order hymenoptera, which includes bees, wasps, hornets, yellow jackets and fire ants), and biting insects (e.g. triatoma, mosquitos), allergen immunotherapy, foods, drugs, diagnostic testing substances (e.g. radiocontrast media), and other allergens, as well as anaphylaxis to unknown substances (idiopathic anaphylaxis) or exercise-induced anaphylaxis. epinephrine auto-injector is intended for immediate administration in patients with a history of anaphylactic reactions. selection of the appropriate dosage strength is determined according to patient body weight (see dosage and administration section). such reactions may occur within minutes after exposure and consist of flushing, apprehension, syncope, tachycardia, thready or unobtainable pulse associated with a fall in blood pressure, convulsions, vomiting, diarrhea and abdominal cramps, involuntary voiding, w

United States - English - NLM (National Library of Medicine)

teva parenteral medicines, inc. - norepinephrine bitartrate (unii: ify5pe3zrw) (norepinephrine - unii:x4w3enh1cv) - norepinephrine 1 mg in 1 ml - norepinephrine bitartrate injection is indicated to raise blood pressure in adult patients with severe, acute hypotension. none. risk summary limited published data consisting of a small number of case reports and multiple small trials involving the use of norepinephrine in pregnant women at the time of delivery have not identified an increased risk of major birth defects, miscarriage or adverse maternal or fetal outcomes. there are risks to the mother and fetus from hypotension associated with septic shock, myocardial infarction and stroke which are medical emergencies in pregnancy and can be fatal if left untreated (see clinical considerations ). in animal reproduction studies, using high doses of intravenous norepinephrine resulted in lowered maternal placental blood flow. clinical relevance to changes in the human fetus is unknown since the average maintenance dose is ten times lower (see data ). increased fetal reabsorptions were observed in pregnant hamsters after receiving daily injections at approxima

Israel - English - Ministry of Health

trupharm marketing 1985 ltd. - epinephrine - solution for injection - epinephrine 0.3 mg / 0.3 ml - epinephrine - epinephrine is indicated in the emergency treatment of severe allergic reactions (type i) including anaphylaxis to stinging insects (e.g., order hymenoptera which includes bees,wasps,hornets,yellow jackets and fire ants) and biting insects (e.g., triatoma, mosquitoes), allergen immunotherapy, foods, drugs,diagnostic testing substances (e.g., radiocontrast media) and other allergens, as well as idiopathic anaphylaxis or exercise induced anaphylaxis.epinephrine is intended for immediate administration in patients who are determined to be at increased risk for anaphylaxis, including individuals with a history of anaphylactic reactions.epinephrine is intended for immediate administration as emergency supportive therapy only, and is not a substitute for immediate medical care

Israel - English - Ministry of Health

trupharm marketing 1985 ltd. - epinephrine - solution for injection - epinephrine 0.15 mg / 0.3 ml - epinephrine - epinephrine is indicated in the emergency treatment of severe allergic reactions (type i) including anaphylaxis to stinging insects (e.g., order hymenoptera which includes bees,wasps,hornets,yellow jackets and fire ants) and biting insects (e.g., triatoma, mosquitoes), allergen immunotherapy, foods, drugs,diagnostic testing substances (e.g., radiocontrast media) and other allergens, as well as idiopathic anaphylaxis or exercise induced anaphylaxis.epinephrine is intended for immediate administration in patients who are determined to be at increased risk for anaphylaxis, including individuals with a history of anaphylactic reactions.epinephrine is intended for immediate administration as emergency supportive therapy only, and is not a substitute for immediate medical care

United States - English - NLM (National Library of Medicine)

avpak - olanzapine (unii: n7u69t4szr) (olanzapine - unii:n7u69t4szr) - olanzapine 5 mg -            oral olanzapine is indicated for the treatment of schizophrenia. efficacy was established in three clinical trials in adult patients with schizophrenia: two 6-week trials and one maintenance trial. in adolescent patients with schizophrenia (ages 13 to 17), efficacy was established in one 6-week trial [see clinical studies (14.1)] .            when deciding among the alternative treatments available for adolescents, clinicians should consider the increased potential (in adolescents as compared with adults) for weight gain and dyslipidemia. clinicians should consider the potential long-term risks when prescribing to adolescents, and in many cases this may lead them to consider prescribing other drugs first in adolescents [see warnings and precautions (5.5)] .             monotherapy — oral olanzapine is indicated for the acute treatment of manic or mixed episodes associated with bipolar i disorder and maintenance treatment of bipolar i disorder. efficacy w

Australia - English - Department of Health (Therapeutic Goods Administration)

ego pharmaceuticals pty ltd - tar, quantity: 23 mg/g - solution - excipient ingredients: solvent green 3; isopropyl myristate; laureth-3; light liquid paraffin; fragrance (perfume) - pinetarsol bath oil is a non-greasy, water dispersible oil for dry skin, with pine tar to relieve severe itching and reduce inflammation. use to relieve the symptoms of eczema, dermatitis, psoriasis and other dry, itcy, inflamed or flaky skin conditions.

Australia - English - APVMA (Australian Pesticides and Veterinary Medicines Authority)

ampol australia petroleum pty ltd - liquid paraffin (heavy) - emulsifiable concentrate - liquid paraffin (heavy) ungrouped active 847.0 g/l - insecticide

United States - English - NLM (National Library of Medicine)

nucare pharmaceuticals, inc. - nifedipine (unii: i9zf7l6g2l) (nifedipine - unii:i9zf7l6g2l) - nifedipine 90 mg - nifedipine extended-release tablets are indicated for the treatment of hypertension. it may be used alone or in combination with other antihypertensive agents. concomitant administration with strong p450 inducers, such as rifampin, are contraindicated since the efficacy of nifedipine tablets could be significantly reduced. (see precautions: drug interactions. ) nifedipine must not be used in cases of cardiogenic shock. nifedipine extended-release tablets are contraindicated in patients with a known hypersensitivity to any component of the tablet. the safety and effectiveness of nifedipine in pediatric patients have not been established. although small pharmacokinetic studies have identified an increased half-life and increased c max and auc (see clinical pharmacology: pharmacokinetics and metabolism ), clinical studies of nifedipine did not include sufficient numbers of subjects aged 65 and over to determine whether they respond differently from younger subjects. other reported clinical experience has not id

United States - English - NLM (National Library of Medicine)

a-s medication solutions - carbamazepine (unii: 33cm23913m) (carbamazepine - unii:33cm23913m) - carbamazepine 200 mg - carbamazepine is indicated for use as an anticonvulsant drug. evidence supporting efficacy of carbamazepine as an anticonvulsant was derived from active drug-controlled studies that enrolled patients with the following seizure types: - partial seizures with complex symptomatology (psychomotor, temporal lobe). patients with these seizures appear to show greater improvement than those with other types. - generalized tonic-clonic seizures (grand mal). - mixed seizure patterns which include the above, or other partial or generalized seizures. absence seizures (petit mal) do not appear to be controlled by carbamazepine (see precautions, general). carbamazepine is indicated in the treatment of the pain associated with true trigeminal neuralgia. beneficial results have also been reported in glossopharyngeal neuralgia. this drug is not a simple analgesic and should not be used for the relief of trivial aches or pains. carbamazepine should not be used in patients with a history of previous bone marrow depression, hype